EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Overcoming treatment resistance in cholangiocarcinoma: current strategies, challenges, and prospects

Jiayi Wang, Siyan Liu, Yi Cao, Yong Chen

Frontiers in Cell and Developmental Biology · 02.08.2024 · 12

DOI: 10.3389/fcell.2024.1408852 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 02.08.2024. Verfasst von Jiayi Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: International Medical College, Chongqing Medical University, Chongqing, China. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Significant advancements in our understanding and clinical treatment of cholangiocarcinoma (CCA) have been achieved over the past 5 years. Groundbreaking studies have illuminated the immune landscape and pathological characteristics of the tumor microenvironment in CCA. The development of immune- and metabolism-based classification systems has enabled a nuanced exploration of the tumor microenvironment and the origins of CCA, facilitating a detailed understanding of tumor progression modulation. Despite these insights, targeted therapies have not yet yielded satisfactory clinical results, highlighting the urgent need for innovative therapeutic strategies. This review delineates the complexity and heterogeneity of CCA, examines the current landscape of therapeutic strategies and clinical trials, and delves into the resistance mechanisms underlying targeted therapies. Finally, from a single-cell and spatial transcriptomic perspective, we address the challenge of therapy resistance, discussing emerging mechanisms and potential strategies to overcome this barrier and enhance treatment efficacy.

Schlagwörter

Stichwörter der Autor:innen

cholangiocarcinoma (CCA)resistance in cholangiocarcinomasingle-cell and spatial transcriptomic perspectivetargeted therapiestreatment of cholangiocarcinoma

Autor:innen und Institutionen

  • International Medical College, Chongqing Medical University, Chongqing, China.
  • Second Clinical College, Chongqing Medical University, Chongqing, China.
  • Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Zitieren

APA

Wang, J., Liu, S., Cao, Y., & Chen, Y. (2024). Overcoming treatment resistance in cholangiocarcinoma: current strategies, challenges, and prospects. Frontiers in Cell and Developmental Biology, 12. https://doi.org/10.3389/fcell.2024.1408852

Vancouver

Wang J, Liu S, Cao Y, Chen Y. Overcoming treatment resistance in cholangiocarcinoma: current strategies, challenges, and prospects. Frontiers in Cell and Developmental Biology. 2024;12. doi:10.3389/fcell.2024.1408852

BibTeX
@article{Wang2024,
  author = {Wang, Jiayi and Liu, Siyan and Cao, Yi and Chen, Yong},
  title = {Overcoming treatment resistance in cholangiocarcinoma: current strategies, challenges, and prospects},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2024},
  volume = {12},
  doi = {10.3389/fcell.2024.1408852}
}
Kostenlos starten →